|Systematic (IUPAC) name|
|9-chloro-6-(2-fluorophenyl)- 2-methyl-2,5-diazabicyclo [5.4.0]undeca- 5,8,10,12-tetraen-3-one|
|Legal status||Schedule IV(US)|
|(what is this?)|
Fludiazepam was developed by Hoffman-LaRoche in the 1960s and is marketed in Japan and Taiwan in 0.25mg tablets under the brand name Erispan is a drug which is a benzodiazepine derivative and is closely related to diazepam. It exerts its pharmacological properties via enhancement of GABAergic inhibition. Fludiazepam has 4 times more binding affinity for benzodiazepine receptors than diazepam. It possesses anxiolytic, anticonvulsant, sedative, hypnotic and skeletal muscle relaxant properties.
Fludiazepam has drug abuse potential.